Equities

Gushengtang Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Gushengtang Holdings Ltd

Actions
  • Price (HKD)30.24
  • Today's Change-1.00 / -3.20%
  • Shares traded41.20k
  • 1 Year change-7.66%
  • Beta0.8682
Data delayed at least 15 minutes, as of Feb 16 2026 02:40 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Gushengtang Holdings Ltd is an investment holding company primarily engaged in the provision of traditional Chinese medicine (TCM) medical and health services. The Company operates two segments. The Provision of Healthcare Solutions segment provides traditional Chinese medicine medical and health solutions through a combination of offline and online medical service networks, combining traditional Chinese medicine diagnosis and treatment methods with Western medicine. The Sale of Healthcare Products segment mainly include the sale of medicinal herbs and nourishment. The Company mainly operates its businesses in the domestic market.

  • Revenue in HKD (TTM)3.57bn
  • Net income in HKD397.72m
  • Incorporated2014
  • Employees3.55k
  • Location
    Gushengtang Holdings LtdNo. 761 Dongfeng East RoadUnit 01-04, 36 Floor, Lifeng CentreGUANGZHOU ChinaCHN
  • Websitehttps://www2.gstzy.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.